{"database": "lobbying", "table": "lobbying_activities", "rows": [[3138838, "0ec132e9-6c56-4e05-aa40-ef4a0ab5cb29", "Q1", "ARDELYX, INC.", 401105832, "ARDELYX, INC.", 2024, "first_quarter", "HCR", "H.R.5074 - Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 - To delay incorporation of oral drugs indicated for the reduction, management, or control of the serum phosphate of an individual into the End-Stage Renal Disease (ESRD) Prospective Payment System.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2024-04-02T08:42:57-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3138838"], "units": {}, "query_ms": 0.19336515106260777, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}